Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study.

BACKGROUND The majority of dialysis patients suffer from vitamin D deficiency, which might contribute to an adverse health outcome. We aimed to elucidate whether European dialysis patients with low 25-hydroxyvitamin D (25(OH)D) levels are at increased risk of mortality and specific fatal events. METHODS This was a prospective cohort study of incident dialysis patients in the Netherlands (the NECOSAD). We selected all patients with measured 25(OH)D at 12 months after the start of dialysis, the baseline for our study. By Cox regression analyses, we assessed the impact of 25(OH)D levels on short-term (6 months of follow-up) as well as longer-term mortality (3 years of follow-up). Associations of 25(OH)D levels with cardiovascular and non-cardiovascular mortality were also determined. RESULTS The data from 762 patients (39% females, age 59 ± 15 years, 25(OH)D = 18 ± 11 ng/mL) were available. Fifty-one and 213 patients died during a follow-up of 6 months and 3 years, respectively. After adjustments for possible confounders, the hazard ratio (HR) (with 95% CI) for mortality was 2.0 (1.0-3.8) for short-term and 1.5 (1.0-2.1) for longer-term mortality when comparing patients with 25(OH)D levels ≤ 10 ng/mL with those presenting with 25(OH)D levels > 10 ng/mL. Adjusted HRs for cardiovascular mortality were 2.7 (1.1-6.5) and 1.7 (1.1-2.7) for short- and longer-term mortality, respectively. For non-cardiovascular mortality, we observed no relevant association overall. The impact of 25(OH)D levels on clinical events was modified by parathyroid hormone (PTH) status, with low 25(OH)D levels meaningfully affecting outcomes only in patients with PTH levels above the median of 123 pmol/L. CONCLUSIONS Vitamin D deficiency in dialysis patients is associated with an adverse health outcome, in particular with short-term cardiovascular mortality. Intervention studies are urgently needed to evaluate whether vitamin D supplementation improves health outcomes of dialysis patients.

[1]  W. März,et al.  Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. , 2011, Current drug targets.

[2]  R. Garrick.  25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease , 2010 .

[3]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[4]  J. Souberbielle,et al.  Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Keith C. Norris,et al.  Chronic kidney disease, hypovitaminosis D, and mortality in the United States. , 2009, Kidney international.

[6]  S. Pacini,et al.  Chronic kidney disease and vitamin D: how much is adequate? , 2009, Kidney international.

[7]  G. Navis,et al.  Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism , 2009, Nature Reviews Nephrology.

[8]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[9]  T. Pieber,et al.  Epidemiology of vitamin D insufficiency and cancer mortality. , 2009, Anticancer research.

[10]  K. Kalantar-Zadeh,et al.  Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[11]  S. Bevc,et al.  Vitamin D as a Novel Nontraditional Risk Factor for Mortality in Hemodialysis Patients , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[12]  Henry Blumberg,et al.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  Z. Massy,et al.  Vitamin D affects survival independently of vascular calcification in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[14]  R. Wolfe,et al.  The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Aníbal Ferreira,et al.  25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  S. Mundra,et al.  Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis , 2009 .

[17]  C. Zoccali,et al.  Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.

[18]  C. Chazot,et al.  Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  Z. Massy,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2008, Kidney international.

[21]  L. Adorini,et al.  Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.

[22]  J. Woo,et al.  Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. , 2008, The American journal of clinical nutrition.

[23]  Keith C. Norris,et al.  Hypovitaminosis D in chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[24]  D. Tishkoff,et al.  Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. , 2008, Endocrinology.

[25]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[26]  M. Chonchol,et al.  Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  D. Johnson,et al.  Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. , 2008, Reviews on recent clinical trials.

[28]  N. Bodyak,et al.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals , 2007, Proceedings of the National Academy of Sciences.

[29]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[30]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[31]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[32]  A. Shao,et al.  Risk assessment for vitamin D. , 2007, The American journal of clinical nutrition.

[33]  William A Ghali,et al.  Kaplan-Meier methods yielded misleading results in competing risk scenarios. , 2006, Journal of clinical epidemiology.

[34]  P. Bossuyt,et al.  Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  R. Koerfer,et al.  Vitamin D insufficiency in congestive heart failure: Why and what to do about it? , 2006, Heart Failure Reviews.

[36]  H. Cross,et al.  Vitamin D and calcium deficits predispose for multiple chronic diseases , 2005, European journal of clinical investigation.

[37]  J. Satagopan,et al.  A note on competing risks in survival data analysis , 2004, British Journal of Cancer.

[38]  F. Dekker,et al.  Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  F. Dekker,et al.  Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  B. Hollis,et al.  Defective photoproduction of cholecalciferol in normal and uremic humans. , 1984, The Journal of nutrition.